US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

Omada Health (OMDA): Second Virtual Healthcare Provider Ready to Test the IPO Market

Omada Health (OMDA): Virtual Healthcare Provider Gains IPO Momentum Behind Success of Peer

Omada Health IPO: Stayed Private For Longer, Modest Upside Potential

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Omada delivers virtual care between doctor’s visits, providing an engaging, personalized, and integrated experience for their members that is designed to improve their health</li>
<li>Revenue increased by 38% from $122.8 million to $169.8 million for the years ended December 31, 2023 and 2024, respectively.</li>
<li>The company's last funding round, Series E (February 2022), secured $192 million in a round led by Fidelity Management &amp; Research with a valuation north of $1bn.</li>
</ul>


Omada delivers virtual care between doctor’s visits, providing an engaging, personalized, and integrated experience for their members that is designed to improve their health
Revenue increased by 38% from $122.8 million to $169.8 million for the years ended December 31, 2023 and 2024, respectively.
The company's last funding round, Series E (February 2022), secured $192 million in a round led by Fidelity Management &amp; Research with a valuation north of $1bn.


Omada Health (OMDA): Virtual Healthcare Provider for Chronic Conditions Filed for IPO